Afinitor’s new UK indication launched
September 20, 2012Sales and Marketing Afinitor, CHMP, Novartis, breast cancer
Novartis’ cancer drug Afinitor has been made available in the UK for patients with the most common form of advanced …
RSA announces new Board members
September 20, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Nick Stephens, RSA executive search
Life sciences executive search and interim management specialists RSA has announced the appointment of Nick Stephens as executive chairman, John …
Silence Therapeutics appoints chief medical adviser
September 19, 2012Business Services, Research and Development, Sales and Marketing Michael Khan, Silence Therapeutics
Silence Therapeutics has announced the appointment of Michael Khan to its board of directors as chief medical adviser. Dr Khan …
J&J sets up life science centres
September 19, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing J&J, JJ, R&D, innovation
Johnson & Johnson is to set up what it calls regional innovation centres in a bid to speed up the …
Steven Gillis to join Shire Board of directors
September 19, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Shire, Steven Gillis
Shire has announced that Dr Steven Gillis will join the Board of directors in October this year. On joining the …
Salmonson is new chair of CHMP
September 19, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CHMP, EMA, MPA, Salmonson
Dr Tomas Salmonson has been elected chair of the Committee for Medicinal Products for Human Use (CHMP) for a three-year …
Circassia appoints Stewart Sharpe as VP Commercial Operations
September 19, 2012Medical Communications, Research and Development, Sales and Marketing Circassia, Stewart Sharpe
Speciality biopharma firm Circassia has announced the appointment of Stewart Sharpe to the newly-created position of vice president, Commercial Operations. …
Two new appointments at Pharmalink Consulting
September 18, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kevin Webb, Lorcan Flanagan, Pharmalink
Regulatory affairs specialists Pharmalink Consulting has announced two new appointments. Lorcan Flanagan (pictured) joins as European Business Development manager and …
Boehringer says it is rolling out ‘fully disposable’ biomanufacturing
September 18, 2012Manufacturing and Production Boehringer, CMO, GMP, SUSs
Boehringer Ingelheim says it has developed a production platform for biopharmaceuticals that makes full use disposable technologies both upstream and …
API supply issues lead Lundbeck to drop cancer drug
September 18, 2012Manufacturing and Production Elspar, Lundbeck, Ovation
Danish firm Lundbeck has decided to discontinue supplies of its leukaemia drug Elspar from December after struggling to find a …
UK at centre of Eisai plans
September 18, 2012Research and Development, Sales and Marketing CNS, Cancer Drugs Fund, Eisai, Fycompa, Halaven
Diseases of the central nervous system (CNS) and cancer will be the main areas targeted by Japanese firm Eisai as …
Pfizer issues guide for medicines disposal
September 18, 2012Manufacturing and Production EPA, PRDA, Pfizer
Pfizer has published a guide for the safe disposal of medicines targeted at healthcare professionals and facilities in the US. …
Asia-Pacific – pharma’s new centre of gravity?
September 18, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Asia-Pacific, AstraZeneca
A high-growth region for the pharmaceutical industry, Asia-Pacific incorporates a vast geography with a $20 trillion economy, and is home …
New data for Pfizer arthritis pill
September 18, 2012Research and Development, Sales and Marketing JAK, Pfizer, RA, tofacitinib
Pfizer is to release more data for its investigational rheumatoid arthritis (RA) pill tofacitinib which it hopes will demonstrate its …
Helix Health appoints John Evans as UK commercial manager
September 18, 2012Medical Communications, Research and Development, Sales and Marketing Helix Health, John Evans
Healthcare IT provider Helix Health has recruited John Evans to the role of UK commercial manager to expand its UK …
SHL to Exhibit at 2012 PDA Event in Las Vegas – Inspiring Integration
September 18, 2012Manufacturing and Production auto injector, autoinjector, inspiring integration, pen injector, shl group
With the biopharmaceutical industry’s drug delivery landscape quickly adapting to the introduction of several biologics drugs in recent years, a …
AstraZeneca signs MIT/Harvard research deal
September 17, 2012Business Services, Research and Development, Sales and Marketing AstraZeneca, Deals, Havard, MIT
AstraZeneca has signed a two-year collaboration with an academic institution – affiliated to the illustrious universities MIT and Harvard – …
UCB opens Belgian pilot plant
September 17, 2012Manufacturing and Production Amgen, Belgium, R&D, UCB
UCB has officially opened a new pilot biotech plant at its Braine-L’Alleud site in Belgium.The 5,100 sq. m. facility – …
Pharma manufacturing news in brief
September 17, 2012Manufacturing and Production Ampio, DPT Labs, Ethypharm, ICH, PC Pharma, Ranbaxy
Ranbaxy and PC Pharma unveil new facility investments, Ethypharm will manufacture Ampio drug, DPT Labs is warned by the FDA …
Doctors.net.uk appoints new business development manager
September 17, 2012Business Services, Medical Communications, Sales and Marketing Marc Singh-Jones, doctors.net
The UK’s largest and most active network of medical professionals Doctors.net.uk has appointed Marc Singh-Jones as Business Development manager. In …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
